Successful Treatment of Genital Warts with Ingenol Mebutate Monitored with Optical Coherence Tomography and Reflectance Confocal Microscopy = Successful Treatment of Genital Warts with Ingenol Mebutate Monitored with Optical Coherence Tomography and Reflectance Confocal Microscopy

다국어 초록 (Multilingual Abstract)

Ingenol mebutate (IM) is approved for the treatment of actinic keratosis and induces cell death in precancerous lesions. The efficacy of IM in the treatment of genital warts was investigated in a therapy-refractory patient. The 74-year-old male was treated with IM gel for three consecutive days. Treatment course and efficacy were evaluated by clinical inspection and non-invasive diagnostics namely optical coherence tomography (OCT) and reflectance confocal microscopy (RCM). Within 24 to 48 hours IM induced a strong local inflammatory reaction. One week later a complete response was observed. OCT and RCM showed a strong reaction after treatment with erosions, swelling of cells, and a subepidermal dark band in representative lesions. IM has the advantage of a short treatment period in contrast to other topical treatments and shows a promising clinical outcome. Larger studies are needed to validate the data. (Ann Dermatol 31(4) 434∼437, 2019)

참고문헌 (Reference)

1 Khawaja HT, "Treatment of condyloma acuminatum" 1 : 208-209, 1986

2 Maier T, "Treatment monitoring of topical ingenol mebutate in actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy : a case series" 172 : 816-818, 2015

3 Braun SA, "Successful therapy of condylomata acuminata with ingenol mebutate" 66 : 223-225, 2015

4 von Krogh G, "Selftreatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebocontrolled comparative study" 70 : 105-109, 1994

5 Anderson L, "Randomized, double-blind, doubledummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis" 60 : 934-943, 2009

6 Schöfer H, "Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts" 16 : 642-648, 2006

7 Khawaja HT, "Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata : a prospective study" 76 : 1067-1068, 1989

8 von Braunmühl T, "Optical coherence tomography" 66 : 499-503, 2015

9 von Braunmühl T, "Noninvasive diagnostic imaging in dermatology" 66 : 492-, 2015

10 Reinholz M, "Non-invasive diagnosis of sweat gland dysplasia using optical coherence tomography and reflectance confocal microscopy in a family with anhidrotic ectodermal dysplasia(Christ-Siemens-Touraine syndrome)" 30 : 677-682, 2016

11 Maier T, "Morphology of basal cell carcinoma in high definition optical coherence tomography : en-face and slice imaging mode, and comparison with histology" 27 : e97-e104, 2013

12 Doorbar J, "Molecular biology of human papillomavirus infection and cervical cancer" 110 : 525-541, 2006

13 Fallen RS, "Ingenol mebutate : an introduction" 17 : 1-3, 2012

14 Rosales R, "Immune therapy for human papillomaviruses-related cancers" 5 : 1002-1019, 2014

15 Dietrich A, "Human papillomavirus status, anal cytology and histopathological outcome in HIV-positive patients" 29 : 2011-2018, 2015

16 Yanofsky VR, "Genital warts : a comprehensive review" 5 : 25-36, 2012

17 Rosen RH, "Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses : rapid lesion necrosis followed by lesion-specific immune response" 66 : 486-493, 2012

18 Ogbourne SM, "Antitumor activity of 3-ingenyl angelate : plasma membrane and mitochondrial disruption and necrotic cell death" 64 : 2833-2839, 2004

19 Maier T, "Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology" 168 : 120-128, 2013

20 Gross G, "A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts" 21 : 1404-1412, 2007